Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Sirtuin1 in tracheal aspirate leukocytes: possible role in the development of bronchopulmonary dysplasia in premature infants.

Mody K, Saslow JG, Kathiravan S, Eydelman R, Bhat V, Stahl GE, Pyon K, Bhandari V, Aghai ZH.

J Matern Fetal Neonatal Med. 2012 Aug;25(8):1483-7. doi: 10.3109/14767058.2011.645925. Epub 2012 Jan 25.

PMID:
22272724
2.

Angiopoietin 2 concentrations in infants developing bronchopulmonary dysplasia: attenuation by dexamethasone.

Aghai ZH, Faqiri S, Saslow JG, Nakhla T, Farhath S, Kumar A, Eydelman R, Strande L, Stahl G, Leone P, Bhandari V.

J Perinatol. 2008 Feb;28(2):149-55. Epub 2007 Nov 22.

PMID:
18033304
3.

IFN-γ and IP-10 in tracheal aspirates from premature infants: relationship with bronchopulmonary dysplasia.

Aghai ZH, Saslow JG, Mody K, Eydelman R, Bhat V, Stahl G, Pyon K, Bhandari V.

Pediatr Pulmonol. 2013 Jan;48(1):8-13. doi: 10.1002/ppul.22540. Epub 2012 Mar 19.

PMID:
22431160
4.

Pepsin, a marker of gastric contents, is increased in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia.

Farhath S, He Z, Nakhla T, Saslow J, Soundar S, Camacho J, Stahl G, Shaffer S, Mehta DI, Aghai ZH.

Pediatrics. 2008 Feb;121(2):e253-9. doi: 10.1542/peds.2007-0056.

PMID:
18245400
5.

Respiratory burst activity in bronchopulmonary dysplasia and changes with dexamethasone.

Ballabh P, Simm M, Kumari J, Califano C, Aghai Z, Laborada G, Sison C, Cunningham-Rundles S.

Pediatr Pulmonol. 2003 May;35(5):392-9.

PMID:
12687597
6.

[Decreased SIRT1 expression is related to bronchopulmonary dysplasia in premature infants after oxygen exposure].

Tan F, Dong W, Lei X, Liu X, Li Q, Kang L, Zhao S, Zhang C.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2016 Dec;32(12):1632-1635. Chinese.

PMID:
27916095
7.

High-mobility group box-1 protein in tracheal aspirates from premature infants: relationship with bronchopulmonary dysplasia and steroid therapy.

Aghai ZH, Saslow JG, Meniru C, Porter C, Eydelman R, Bhat V, Stahl G, Sannoh S, Pyon K, Hewitt C, Bhandari V.

J Perinatol. 2010 Sep;30(9):610-5. doi: 10.1038/jp.2010.16. Epub 2010 Feb 25.

PMID:
20182437
8.

Pulmonary trypsin-2 in the development of bronchopulmonary dysplasia in preterm infants.

Cederqvist K, Haglund C, Heikkilä P, Sorsa T, Tervahartiala T, Stenman UH, Andersson S.

Pediatrics. 2003 Sep;112(3 Pt 1):570-7.

PMID:
12949286
9.

Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia.

Ehrenkranz RA, Walsh MC, Vohr BR, Jobe AH, Wright LL, Fanaroff AA, Wrage LA, Poole K; National Institutes of Child Health and Human Development Neonatal Research Network.

Pediatrics. 2005 Dec;116(6):1353-60.

PMID:
16322158
10.

Isolation of tracheal aspirate mesenchymal stromal cells predicts bronchopulmonary dysplasia.

Popova AP, Bozyk PD, Bentley JK, Linn MJ, Goldsmith AM, Schumacher RE, Weiner GM, Filbrun AG, Hershenson MB.

Pediatrics. 2010 Nov;126(5):e1127-33. doi: 10.1542/peds.2009-3445. Epub 2010 Oct 11.

11.

Serial changes in levels of IL-6 and IL-1beta in premature infants at risk for bronchopulmonary dysplasia.

Kazzi SN, Romero R, McLaughlin K, Ager J, Janisse J.

Pediatr Pulmonol. 2001 Mar;31(3):220-6.

PMID:
11276135
12.

Value of serum and bronchoalveolar fluid lavage pro- and anti-inflammatory cytokine levels for predicting bronchopulmonary dysplasia in premature infants.

Köksal N, Kayik B, Çetinkaya M, Özkan H, Budak F, Kiliç Ş, Canitez Y, Oral B.

Eur Cytokine Netw. 2012 Jun;23(2):29-35. doi: 10.1684/ecn.2012.0304.

14.

Peptide growth factors in tracheal aspirates of mechanically ventilated preterm neonates.

Ambalavanan N, Novak ZE.

Pediatr Res. 2003 Feb;53(2):240-4.

PMID:
12538781
15.

Time-related changes in steroid use and bronchopulmonary dysplasia in preterm infants.

Yoder BA, Harrison M, Clark RH.

Pediatrics. 2009 Aug;124(2):673-9. doi: 10.1542/peds.2008-2793. Epub 2009 Jul 20.

PMID:
19620192
16.

Soluble interleukin-2 receptor levels in infants with bronchopulmonary dysplasia.

Stefano JL, Spear ML, Pearlman SA, Fawcett P, Proujansky R.

Pediatr Pulmonol. 1992 Sep;14(1):58-62.

PMID:
1437345
17.

Plasma 3-nitrotyrosine is elevated in premature infants who develop bronchopulmonary dysplasia.

Banks BA, Ischiropoulos H, McClelland M, Ballard PL, Ballard RA.

Pediatrics. 1998 May;101(5):870-4.

PMID:
9565417
18.

Soluble E-selectin, soluble L-selectin and soluble ICAM-1 in bronchopulmonary dysplasia, and changes with dexamethasone.

Ballabh P, Kumari J, Krauss AN, Shin JJ, Jain A, Auld PA, Lesser ML, Cunningham-Rundles S.

Pediatrics. 2003 Mar;111(3):461-8.

PMID:
12612222
19.

Increase of interleukin-6 in tracheal aspirate at birth: a predictor of subsequent bronchopulmonary dysplasia in preterm infants.

Choi CW, Kim BI, Kim HS, Park JD, Choi JH, Son DW.

Acta Paediatr. 2006 Jan;95(1):38-43.

PMID:
16373294
20.

Comparison of tracheal aspirate and bronchoalveolar lavage specimens from premature infants.

D'Angio CT, Basavegowda K, Avissar NE, Finkelstein JN, Sinkin RA.

Biol Neonate. 2002;82(3):145-9.

PMID:
12373063

Supplemental Content

Support Center